Pleural Cavity

  • 3E0L0 - Open
    • 3E0L05
      • 3E0L05Z - Introduction Pleural Cavity to No Qualifier with Adhesion Barrier, Open Approach
  • 3E0L3 - Percutaneous
    • 3E0L30
      • 3E0L304 - Introduction Pleural Cavity to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach
      • 3E0L305 - Introduction Pleural Cavity to Other Antineoplastic with Antineoplastic, Percutaneous Approach
      • 3E0L30M - Introduction Pleural Cavity to Monoclonal Antibody with Antineoplastic, Percutaneous Approach
    • 3E0L31
      • 3E0L317 - Introduction Pleural Cavity to Other Thrombolytic with Thrombolytic, Percutaneous Approach
    • 3E0L32
      • 3E0L328 - Introduction Pleural Cavity to Oxazolidinones with Anti-infective, Percutaneous Approach
      • 3E0L329 - Introduction Pleural Cavity to Other Anti-infective with Anti-infective, Percutaneous Approach
    • 3E0L33
      • 3E0L33Z - Introduction Pleural Cavity to No Qualifier with Anti-inflammatory, Percutaneous Approach
    • 3E0L35
      • 3E0L35Z - Introduction Pleural Cavity to No Qualifier with Adhesion Barrier, Percutaneous Approach
    • 3E0L36
      • 3E0L36Z - Introduction Pleural Cavity to No Qualifier with Nutritional Substance, Percutaneous Approach
    • 3E0L37
      • 3E0L37Z - Introduction Pleural Cavity to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach
    • 3E0L3B
      • 3E0L3BZ - Introduction Pleural Cavity to No Qualifier with Anesthetic Agent, Percutaneous Approach
    • 3E0L3G
      • 3E0L3GC - Introduction Pleural Cavity to Other Substance with Other Therapeutic Substance, Percutaneous Approach
    • 3E0L3H
      • 3E0L3HZ - Introduction Pleural Cavity to No Qualifier with Radioactive Substance, Percutaneous Approach
    • 3E0L3K
      • 3E0L3KZ - Introduction Pleural Cavity to No Qualifier with Other Diagnostic Substance, Percutaneous Approach
    • 3E0L3N
      • 3E0L3NZ - Introduction Pleural Cavity to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach
    • 3E0L3S
      • 3E0L3SF - Introduction Pleural Cavity to Other Gas with Gas, Percutaneous Approach
    • 3E0L3T
      • 3E0L3TZ - Introduction Pleural Cavity to No Qualifier with Destructive Agent, Percutaneous Approach
  • 3E0L4 - Percutaneous Endoscopic
    • 3E0L45
      • 3E0L45Z - Introduction Pleural Cavity to No Qualifier with Adhesion Barrier, Percutaneous Endoscopic Approach
    • 3E0L4G
      • 3E0L4GC - Introduction Pleural Cavity to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach
  • 3E0L7 - Via Natural or Artificial Opening
    • 3E0L70
      • 3E0L704 - Introduction Pleural Cavity to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach
      • 3E0L705 - Introduction Pleural Cavity to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach
      • 3E0L70M - Introduction Pleural Cavity to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach
    • 3E0L7S
      • 3E0L7SF - Introduction Pleural Cavity to Other Gas with Gas, Via Natural or Artificial Opening Approach